BioSpace News Archive

ViewRay, Inc. (NASDAQ: VRAY) today announced that the Company will participate in two upcoming investor conferences in New York, NY.

CVS Health Corporation announced the results of the previously announced cash tender offers for any and all of its 3.125% Senior Notes due 2020 and any and all of its 4.125% Senior Notes due 2021, the 4.125% Senior Notes due 2021 issued by its wholly-owned subsidiary, Aetna Inc. and the 5.450% Senior Notes due 2021 issued by Coventry Health Care, Inc., a wholly-owned subsidiary of Aetna.

Ankura, a leading business advisory and expert services firm that provides integrated corporate performance and risk management services, including compliance, investigations, forensics, technology, turnaround and restructuring, and strategic management consulting capabilities, today announced the appointment of Richard Merino to Senior Managing Director.

Loop Genomics, the single molecule long-read sequencing company with a hardware free solution, has expanded its kit and services capabilities to provide researchers with a new kit and service solution for de novo Bacterial Genome Assembly using long-reads on Illumina sequencers.

Addition Supports The CIGC Recent Expansion in New York and New Jersey

CTD Holdings, Inc. (OTCQB: CTDH), a clinical stage biotechnology company that develops cyclodextrin-based products for the treatment of disease with unmet medical need, today posted its presentation to be made at the annual Family Support and Medical Conference organized by the National Niemann-Pick Disease Foundation (NNPDF).

IQVIA™ (NYSE:IQV) announces its launch of the IQVIA Patient Portal, a global web-based solution built on a leading health cloud platform.

Vireo Health International, Inc. (“Vireo” or the “Company”) (CNSX: VREO, OTCQX: VREOF), a leading physician-led, science-focused multi-state cannabis company, today announced that the Company’s affiliate, Ohio Medical Solutions (“OMS”), was granted a Certificate of Operation by the Ohio Department of Commerce.

V-Wave Ltd., a privately held medical device company developing novel implantable interatrial shunt devices, today announced that the U.S. Food and Drug Administration (FDA) has just granted the company a Breakthrough Device Designation for its interatrial shunt for Heart Failure (HF).

Agilent Technologies Inc. (NYSE: A) today announced that Dr. Gang Yu, a professor at the School of Environment at Tsinghua University in Beijing, China, has received an Agilent Thought Leader Award.